nodes	percent_of_prediction	percent_of_DWPC	metapath
Diethylstilbestrol—COMT—attention deficit hyperactivity disorder	0.873	1	CbGaD
Diethylstilbestrol—COMT—Enzymatic degradation of Dopamine by monoamine oxidase—MAOA—attention deficit hyperactivity disorder	0.00977	0.163	CbGpPWpGaD
Diethylstilbestrol—COMT—Clearance of dopamine—SLC6A3—attention deficit hyperactivity disorder	0.00837	0.14	CbGpPWpGaD
Diethylstilbestrol—COMT—Clearance of dopamine—MAOA—attention deficit hyperactivity disorder	0.00707	0.118	CbGpPWpGaD
Diethylstilbestrol—ESRRG—midbrain—attention deficit hyperactivity disorder	0.00398	0.0596	CbGeAlD
Diethylstilbestrol—COMT—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—attention deficit hyperactivity disorder	0.00382	0.0638	CbGpPWpGaD
Diethylstilbestrol—ESRRG—nervous system—attention deficit hyperactivity disorder	0.00328	0.049	CbGeAlD
Diethylstilbestrol—COMT—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—attention deficit hyperactivity disorder	0.00322	0.0539	CbGpPWpGaD
Diethylstilbestrol—ESRRG—central nervous system—attention deficit hyperactivity disorder	0.00315	0.0472	CbGeAlD
Diethylstilbestrol—ESRRG—cerebellum—attention deficit hyperactivity disorder	0.00308	0.0461	CbGeAlD
Diethylstilbestrol—TTR—forebrain—attention deficit hyperactivity disorder	0.00259	0.0388	CbGeAlD
Diethylstilbestrol—ESRRG—brain—attention deficit hyperactivity disorder	0.0025	0.0375	CbGeAlD
Diethylstilbestrol—TTR—cardiovascular system—attention deficit hyperactivity disorder	0.00219	0.0328	CbGeAlD
Diethylstilbestrol—COMT—Dopamine metabolism—MAOA—attention deficit hyperactivity disorder	0.00219	0.0365	CbGpPWpGaD
Diethylstilbestrol—ESR2—forebrain—attention deficit hyperactivity disorder	0.00206	0.0308	CbGeAlD
Diethylstilbestrol—COMT—forebrain—attention deficit hyperactivity disorder	0.00196	0.0294	CbGeAlD
Diethylstilbestrol—COMT—Biogenic Amine Synthesis—MAOA—attention deficit hyperactivity disorder	0.00195	0.0326	CbGpPWpGaD
Diethylstilbestrol—ESR2—cardiovascular system—attention deficit hyperactivity disorder	0.00174	0.0261	CbGeAlD
Diethylstilbestrol—TTR—midbrain—attention deficit hyperactivity disorder	0.00171	0.0256	CbGeAlD
Diethylstilbestrol—COMT—cardiovascular system—attention deficit hyperactivity disorder	0.00166	0.0248	CbGeAlD
Diethylstilbestrol—CYP19A1—forebrain—attention deficit hyperactivity disorder	0.00162	0.0243	CbGeAlD
Diethylstilbestrol—ESR1—forebrain—attention deficit hyperactivity disorder	0.00141	0.0211	CbGeAlD
Diethylstilbestrol—TTR—nervous system—attention deficit hyperactivity disorder	0.00141	0.021	CbGeAlD
Diethylstilbestrol—TTR—central nervous system—attention deficit hyperactivity disorder	0.00135	0.0203	CbGeAlD
Diethylstilbestrol—TTR—cerebellum—attention deficit hyperactivity disorder	0.00132	0.0198	CbGeAlD
Diethylstilbestrol—COMT—midbrain—attention deficit hyperactivity disorder	0.0013	0.0194	CbGeAlD
Diethylstilbestrol—ESR1—cardiovascular system—attention deficit hyperactivity disorder	0.00119	0.0178	CbGeAlD
Diethylstilbestrol—ESR2—nervous system—attention deficit hyperactivity disorder	0.00112	0.0167	CbGeAlD
Diethylstilbestrol—ESR2—central nervous system—attention deficit hyperactivity disorder	0.00108	0.0161	CbGeAlD
Diethylstilbestrol—TTR—brain—attention deficit hyperactivity disorder	0.00107	0.0161	CbGeAlD
Diethylstilbestrol—COMT—nervous system—attention deficit hyperactivity disorder	0.00107	0.0159	CbGeAlD
Diethylstilbestrol—CYP2A6—cerebellum—attention deficit hyperactivity disorder	0.00106	0.0158	CbGeAlD
Diethylstilbestrol—ESR2—cerebellum—attention deficit hyperactivity disorder	0.00105	0.0157	CbGeAlD
Diethylstilbestrol—COMT—central nervous system—attention deficit hyperactivity disorder	0.00103	0.0154	CbGeAlD
Diethylstilbestrol—AOX1—cerebellum—attention deficit hyperactivity disorder	0.00101	0.0151	CbGeAlD
Diethylstilbestrol—COMT—cerebellum—attention deficit hyperactivity disorder	0.001	0.015	CbGeAlD
Diethylstilbestrol—CYP19A1—nervous system—attention deficit hyperactivity disorder	0.000881	0.0132	CbGeAlD
Diethylstilbestrol—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.000872	0.0131	CbGeAlD
Diethylstilbestrol—ABCG2—Fluoropyrimidine Activity—DPYD—attention deficit hyperactivity disorder	0.000863	0.0144	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—brain—attention deficit hyperactivity disorder	0.000858	0.0128	CbGeAlD
Diethylstilbestrol—ESR2—brain—attention deficit hyperactivity disorder	0.000854	0.0128	CbGeAlD
Diethylstilbestrol—CYP19A1—central nervous system—attention deficit hyperactivity disorder	0.000848	0.0127	CbGeAlD
Diethylstilbestrol—CYP2E1—cardiovascular system—attention deficit hyperactivity disorder	0.000827	0.0124	CbGeAlD
Diethylstilbestrol—AOX1—brain—attention deficit hyperactivity disorder	0.000822	0.0123	CbGeAlD
Diethylstilbestrol—COMT—brain—attention deficit hyperactivity disorder	0.000814	0.0122	CbGeAlD
Diethylstilbestrol—COMT—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.000797	0.0133	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—Fluoropyrimidine Activity—DPYD—attention deficit hyperactivity disorder	0.000784	0.0131	CbGpPWpGaD
Diethylstilbestrol—ESR1—nervous system—attention deficit hyperactivity disorder	0.000765	0.0115	CbGeAlD
Diethylstilbestrol—ABCG2—midbrain—attention deficit hyperactivity disorder	0.000746	0.0112	CbGeAlD
Diethylstilbestrol—ESR1—central nervous system—attention deficit hyperactivity disorder	0.000737	0.011	CbGeAlD
Diethylstilbestrol—ESR1—cerebellum—attention deficit hyperactivity disorder	0.00072	0.0108	CbGeAlD
Diethylstilbestrol—CYP19A1—FSH signaling pathway—BDNF—attention deficit hyperactivity disorder	0.000682	0.0114	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—brain—attention deficit hyperactivity disorder	0.000673	0.0101	CbGeAlD
Diethylstilbestrol—TTR—Extracellular matrix organization—MMP16—attention deficit hyperactivity disorder	0.000669	0.0112	CbGpPWpGaD
Diethylstilbestrol—COMT—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.000611	0.0102	CbGpPWpGaD
Diethylstilbestrol—ESRRG—Gene Expression—POLR3A—attention deficit hyperactivity disorder	0.000602	0.0101	CbGpPWpGaD
Diethylstilbestrol—ESR1—brain—attention deficit hyperactivity disorder	0.000585	0.00876	CbGeAlD
Diethylstilbestrol—ABCG2—cerebellum—attention deficit hyperactivity disorder	0.000577	0.00863	CbGeAlD
Diethylstilbestrol—ABCB1—forebrain—attention deficit hyperactivity disorder	0.000557	0.00833	CbGeAlD
Diethylstilbestrol—CYP2E1—nervous system—attention deficit hyperactivity disorder	0.000531	0.00794	CbGeAlD
Diethylstilbestrol—ESR2—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.000513	0.00857	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—central nervous system—attention deficit hyperactivity disorder	0.000511	0.00765	CbGeAlD
Diethylstilbestrol—CYP2E1—cerebellum—attention deficit hyperactivity disorder	0.000499	0.00748	CbGeAlD
Diethylstilbestrol—CYP2C8—brain—attention deficit hyperactivity disorder	0.000482	0.00721	CbGeAlD
Diethylstilbestrol—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.000471	0.00705	CbGeAlD
Diethylstilbestrol—ABCG2—brain—attention deficit hyperactivity disorder	0.000469	0.00701	CbGeAlD
Diethylstilbestrol—ESR2—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.000441	0.00737	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.000427	0.00639	CbGeAlD
Diethylstilbestrol—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.000411	0.00615	CbGeAlD
Diethylstilbestrol—ESR2—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.00041	0.00685	CbGpPWpGaD
Diethylstilbestrol—ESR2—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.00041	0.00685	CbGpPWpGaD
Diethylstilbestrol—COMT—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000408	0.00682	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—brain—attention deficit hyperactivity disorder	0.000406	0.00607	CbGeAlD
Diethylstilbestrol—ABCB1—midbrain—attention deficit hyperactivity disorder	0.000368	0.0055	CbGeAlD
Diethylstilbestrol—COMT—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000351	0.00586	CbGpPWpGaD
Diethylstilbestrol—COMT—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000326	0.00545	CbGpPWpGaD
Diethylstilbestrol—COMT—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000313	0.00522	CbGpPWpGaD
Diethylstilbestrol—ESR2—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.000309	0.00515	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000303	0.00505	CbGpPWpGaD
Diethylstilbestrol—ABCB1—nervous system—attention deficit hyperactivity disorder	0.000302	0.00452	CbGeAlD
Diethylstilbestrol—ESR2—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.000298	0.00497	CbGpPWpGaD
Diethylstilbestrol—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.000291	0.00436	CbGeAlD
Diethylstilbestrol—COMT—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000291	0.00486	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.000287	0.0048	CbGpPWpGaD
Diethylstilbestrol—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.000284	0.00426	CbGeAlD
Diethylstilbestrol—COMT—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000277	0.00463	CbGpPWpGaD
Diethylstilbestrol—ESR2—Validated nuclear estrogen receptor alpha network—EP300—attention deficit hyperactivity disorder	0.000272	0.00454	CbGpPWpGaD
Diethylstilbestrol—COMT—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000269	0.00449	CbGpPWpGaD
Diethylstilbestrol—ESR2—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.000253	0.00423	CbGpPWpGaD
Diethylstilbestrol—ESR2—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000251	0.0042	CbGpPWpGaD
Diethylstilbestrol—COMT—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00025	0.00418	CbGpPWpGaD
Diethylstilbestrol—COMT—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000246	0.0041	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000241	0.00402	CbGpPWpGaD
Diethylstilbestrol—ABCB1—brain—attention deficit hyperactivity disorder	0.000231	0.00346	CbGeAlD
Diethylstilbestrol—COMT—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000223	0.00372	CbGpPWpGaD
Diethylstilbestrol—ABCG2—HIF-2-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.000222	0.00372	CbGpPWpGaD
Diethylstilbestrol—TTR—Disease—STUB1—attention deficit hyperactivity disorder	0.000209	0.0035	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.000194	0.00324	CbGpPWpGaD
Diethylstilbestrol—ESR1—FOXM1 transcription factor network—EP300—attention deficit hyperactivity disorder	0.000192	0.00321	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00019	0.00318	CbGpPWpGaD
Diethylstilbestrol—COMT—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000188	0.00314	CbGpPWpGaD
Diethylstilbestrol—TTR—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000188	0.00314	CbGpPWpGaD
Diethylstilbestrol—ESR1—FOXA1 transcription factor network—EP300—attention deficit hyperactivity disorder	0.000185	0.00309	CbGpPWpGaD
Diethylstilbestrol—ESR1—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.000178	0.00298	CbGpPWpGaD
Diethylstilbestrol—AOX1—Disease—STUB1—attention deficit hyperactivity disorder	0.000178	0.00297	CbGpPWpGaD
Diethylstilbestrol—ABCG2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000175	0.00292	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.000173	0.00289	CbGpPWpGaD
Diethylstilbestrol—ABCG2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000167	0.00279	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000164	0.00275	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000162	0.0027	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000161	0.00268	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00016	0.00267	CbGpPWpGaD
Diethylstilbestrol—TTR—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000146	0.00245	CbGpPWpGaD
Diethylstilbestrol—ESR1—ATF-2 transcription factor network—EP300—attention deficit hyperactivity disorder	0.000146	0.00244	CbGpPWpGaD
Diethylstilbestrol—ESR1—Validated nuclear estrogen receptor alpha network—EP300—attention deficit hyperactivity disorder	0.000137	0.00229	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000134	0.00224	CbGpPWpGaD
Diethylstilbestrol—ESR2—Gene Expression—POLR3A—attention deficit hyperactivity disorder	0.000133	0.00223	CbGpPWpGaD
Diethylstilbestrol—ESR2—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000133	0.00223	CbGpPWpGaD
Diethylstilbestrol—ABCG2—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.000131	0.00219	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000129	0.00215	CbGpPWpGaD
Diethylstilbestrol—AOX1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000128	0.00214	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000128	0.00214	CbGpPWpGaD
Diethylstilbestrol—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.000128	0.00213	CbGpPWpGaD
Diethylstilbestrol—ESR1—AP-1 transcription factor network—EP300—attention deficit hyperactivity disorder	0.000128	0.00213	CbGpPWpGaD
Diethylstilbestrol—TTR—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000126	0.0021	CbGpPWpGaD
Diethylstilbestrol—TTR—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000123	0.00206	CbGpPWpGaD
Diethylstilbestrol—TTR—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000121	0.00202	CbGpPWpGaD
Diethylstilbestrol—COMT—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000114	0.00191	CbGpPWpGaD
Diethylstilbestrol—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—attention deficit hyperactivity disorder	0.000113	0.0019	CbGpPWpGaD
Diethylstilbestrol—ESR2—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000113	0.00189	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000102	0.0017	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000101	0.00169	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.0001	0.00168	CbGpPWpGaD
Diethylstilbestrol—TTR—Disease—SNAP25—attention deficit hyperactivity disorder	9.92e-05	0.00166	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	9.46e-05	0.00158	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	9.03e-05	0.00151	CbGpPWpGaD
Diethylstilbestrol—AOX1—Metabolism—TPH2—attention deficit hyperactivity disorder	8.83e-05	0.00148	CbGpPWpGaD
Diethylstilbestrol—AOX1—Metabolism—CACNB2—attention deficit hyperactivity disorder	8.83e-05	0.00148	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	8.83e-05	0.00148	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Biological oxidations—COMT—attention deficit hyperactivity disorder	8.8e-05	0.00147	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Biological oxidations—MAOA—attention deficit hyperactivity disorder	8.74e-05	0.00146	CbGpPWpGaD
Diethylstilbestrol—AOX1—Metabolism—DPYD—attention deficit hyperactivity disorder	8.69e-05	0.00145	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	8.68e-05	0.00145	CbGpPWpGaD
Diethylstilbestrol—TTR—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	8.55e-05	0.00143	CbGpPWpGaD
Diethylstilbestrol—AOX1—Disease—SNAP25—attention deficit hyperactivity disorder	8.43e-05	0.00141	CbGpPWpGaD
Diethylstilbestrol—AOX1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	8.08e-05	0.00135	CbGpPWpGaD
Diethylstilbestrol—COMT—Metabolism—TPH2—attention deficit hyperactivity disorder	7.87e-05	0.00132	CbGpPWpGaD
Diethylstilbestrol—COMT—Metabolism—CACNB2—attention deficit hyperactivity disorder	7.87e-05	0.00132	CbGpPWpGaD
Diethylstilbestrol—COMT—Metabolism—DPYD—attention deficit hyperactivity disorder	7.75e-05	0.00129	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—Integrated Breast Cancer Pathway—EP300—attention deficit hyperactivity disorder	7.7e-05	0.00129	CbGpPWpGaD
Diethylstilbestrol—TTR—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	7.47e-05	0.00125	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	7.39e-05	0.00123	CbGpPWpGaD
Diethylstilbestrol—COMT—Metabolism—CACNA1C—attention deficit hyperactivity disorder	7.2e-05	0.0012	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Biological oxidations—COMT—attention deficit hyperactivity disorder	7.16e-05	0.0012	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	7.11e-05	0.00119	CbGpPWpGaD
Diethylstilbestrol—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	7.07e-05	0.00118	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	7.06e-05	0.00118	CbGpPWpGaD
Diethylstilbestrol—AOX1—Metabolism—SNAP25—attention deficit hyperactivity disorder	7.06e-05	0.00118	CbGpPWpGaD
Diethylstilbestrol—TTR—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	6.95e-05	0.00116	CbGpPWpGaD
Diethylstilbestrol—ESR1—Integrated Breast Cancer Pathway—EP300—attention deficit hyperactivity disorder	6.9e-05	0.00115	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	6.75e-05	0.00113	CbGpPWpGaD
Diethylstilbestrol—TTR—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	6.73e-05	0.00112	CbGpPWpGaD
Diethylstilbestrol—AOX1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.72e-05	0.00112	CbGpPWpGaD
Diethylstilbestrol—ESR1—Gene Expression—POLR3A—attention deficit hyperactivity disorder	6.72e-05	0.00112	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	6.62e-05	0.00111	CbGpPWpGaD
Diethylstilbestrol—TTR—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	6.61e-05	0.0011	CbGpPWpGaD
Diethylstilbestrol—TTR—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	6.53e-05	0.00109	CbGpPWpGaD
Diethylstilbestrol—COMT—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.29e-05	0.00105	CbGpPWpGaD
Diethylstilbestrol—ABCG2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	6.09e-05	0.00102	CbGpPWpGaD
Diethylstilbestrol—TTR—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	6.08e-05	0.00102	CbGpPWpGaD
Diethylstilbestrol—COMT—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.99e-05	0.001	CbGpPWpGaD
Diethylstilbestrol—ABCG2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	5.8e-05	0.000969	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	5.77e-05	0.000963	CbGpPWpGaD
Diethylstilbestrol—ESR1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	5.71e-05	0.000955	CbGpPWpGaD
Diethylstilbestrol—AOX1—Metabolism—COMT—attention deficit hyperactivity disorder	5.35e-05	0.000894	CbGpPWpGaD
Diethylstilbestrol—AOX1—Metabolism—MAOA—attention deficit hyperactivity disorder	5.31e-05	0.000888	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	5.27e-05	0.00088	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	4.95e-05	0.000828	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	4.85e-05	0.000811	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	4.76e-05	0.000795	CbGpPWpGaD
Diethylstilbestrol—COMT—Metabolism—MAOA—attention deficit hyperactivity disorder	4.74e-05	0.000791	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	4.72e-05	0.000789	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	4.69e-05	0.000784	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	4.66e-05	0.000778	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—Metabolism—TPH2—attention deficit hyperactivity disorder	4.57e-05	0.000763	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	4.57e-05	0.000763	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—Metabolism—DPYD—attention deficit hyperactivity disorder	4.49e-05	0.000751	CbGpPWpGaD
Diethylstilbestrol—TTR—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.26e-05	0.000712	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	4.18e-05	0.000698	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	4.16e-05	0.000696	CbGpPWpGaD
Diethylstilbestrol—ABCG2—Metabolism—TPH2—attention deficit hyperactivity disorder	4e-05	0.000669	CbGpPWpGaD
Diethylstilbestrol—ABCG2—Metabolism—CACNB2—attention deficit hyperactivity disorder	4e-05	0.000669	CbGpPWpGaD
Diethylstilbestrol—ABCG2—Metabolism—DPYD—attention deficit hyperactivity disorder	3.94e-05	0.000658	CbGpPWpGaD
Diethylstilbestrol—ABCG2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	3.66e-05	0.000612	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	3.65e-05	0.00061	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—Metabolism—TPH2—attention deficit hyperactivity disorder	3.64e-05	0.000608	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—Metabolism—CACNB2—attention deficit hyperactivity disorder	3.64e-05	0.000608	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.6e-05	0.000601	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—Metabolism—DPYD—attention deficit hyperactivity disorder	3.58e-05	0.000598	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.48e-05	0.000581	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	3.36e-05	0.000562	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	3.33e-05	0.000556	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	3.29e-05	0.00055	CbGpPWpGaD
Diethylstilbestrol—TTR—Disease—EP300—attention deficit hyperactivity disorder	3.22e-05	0.000539	CbGpPWpGaD
Diethylstilbestrol—ABCG2—Metabolism—SNAP25—attention deficit hyperactivity disorder	3.2e-05	0.000535	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.14e-05	0.000524	CbGpPWpGaD
Diethylstilbestrol—ABCG2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.05e-05	0.000509	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	3.02e-05	0.000505	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.94e-05	0.000491	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.93e-05	0.000489	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.91e-05	0.000486	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Metabolism—TPH2—attention deficit hyperactivity disorder	2.87e-05	0.00048	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.87e-05	0.00048	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Metabolism—DPYD—attention deficit hyperactivity disorder	2.83e-05	0.000472	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—Metabolism—COMT—attention deficit hyperactivity disorder	2.77e-05	0.000462	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.77e-05	0.000462	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—Metabolism—MAOA—attention deficit hyperactivity disorder	2.75e-05	0.000459	CbGpPWpGaD
Diethylstilbestrol—AOX1—Disease—EP300—attention deficit hyperactivity disorder	2.74e-05	0.000458	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.73e-05	0.000457	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	2.67e-05	0.000445	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.65e-05	0.000442	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.63e-05	0.000439	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.6e-05	0.000435	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.57e-05	0.000429	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism—TPH2—attention deficit hyperactivity disorder	2.48e-05	0.000415	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.48e-05	0.000415	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism—DPYD—attention deficit hyperactivity disorder	2.44e-05	0.000408	CbGpPWpGaD
Diethylstilbestrol—ABCG2—Metabolism—COMT—attention deficit hyperactivity disorder	2.42e-05	0.000405	CbGpPWpGaD
Diethylstilbestrol—ABCG2—Metabolism—MAOA—attention deficit hyperactivity disorder	2.41e-05	0.000402	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.39e-05	0.0004	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.3e-05	0.000384	CbGpPWpGaD
Diethylstilbestrol—AOX1—Metabolism—EP300—attention deficit hyperactivity disorder	2.3e-05	0.000383	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.27e-05	0.00038	CbGpPWpGaD
Diethylstilbestrol—TTR—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.26e-05	0.000377	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—Metabolism—COMT—attention deficit hyperactivity disorder	2.2e-05	0.000368	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—Metabolism—MAOA—attention deficit hyperactivity disorder	2.19e-05	0.000365	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.19e-05	0.000365	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	2.16e-05	0.000362	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.16e-05	0.000362	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	2.13e-05	0.000356	CbGpPWpGaD
Diethylstilbestrol—COMT—Metabolism—EP300—attention deficit hyperactivity disorder	2.05e-05	0.000342	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	2.02e-05	0.000338	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.02e-05	0.000338	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	1.99e-05	0.000332	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.99e-05	0.000332	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.98e-05	0.000331	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.93e-05	0.000323	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.89e-05	0.000316	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.85e-05	0.000309	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Metabolism—COMT—attention deficit hyperactivity disorder	1.74e-05	0.000291	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.73e-05	0.000289	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Metabolism—MAOA—attention deficit hyperactivity disorder	1.73e-05	0.000289	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.68e-05	0.00028	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.65e-05	0.000275	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.62e-05	0.00027	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.54e-05	0.000257	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism—COMT—attention deficit hyperactivity disorder	1.5e-05	0.000251	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism—MAOA—attention deficit hyperactivity disorder	1.49e-05	0.00025	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	1.45e-05	0.000242	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	1.33e-05	0.000223	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.33e-05	0.000223	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	1.31e-05	0.000219	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	1.31e-05	0.000219	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	1.3e-05	0.000217	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	1.22e-05	0.000205	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.22e-05	0.000204	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	1.22e-05	0.000203	CbGpPWpGaD
Diethylstilbestrol—CYP19A1—Metabolism—EP300—attention deficit hyperactivity disorder	1.19e-05	0.000198	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	1.18e-05	0.000197	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.07e-05	0.000178	CbGpPWpGaD
Diethylstilbestrol—ABCG2—Metabolism—EP300—attention deficit hyperactivity disorder	1.04e-05	0.000174	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.01e-05	0.00017	CbGpPWpGaD
Diethylstilbestrol—CYP2A6—Metabolism—EP300—attention deficit hyperactivity disorder	9.45e-06	0.000158	CbGpPWpGaD
Diethylstilbestrol—ESR1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	8.89e-06	0.000148	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	8.08e-06	0.000135	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	8.02e-06	0.000134	CbGpPWpGaD
Diethylstilbestrol—CYP2E1—Metabolism—EP300—attention deficit hyperactivity disorder	7.47e-06	0.000125	CbGpPWpGaD
Diethylstilbestrol—CYP2C8—Metabolism—EP300—attention deficit hyperactivity disorder	6.45e-06	0.000108	CbGpPWpGaD
Diethylstilbestrol—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	5.62e-06	9.39e-05	CbGpPWpGaD
Diethylstilbestrol—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	5.25e-06	8.78e-05	CbGpPWpGaD
Diethylstilbestrol—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	3.46e-06	5.79e-05	CbGpPWpGaD
